Skip to main content
Top
Published in: Cancer Cell International 1/2014

Open Access 01-12-2014 | Primary research

Electromagnetic field investigation on different cancer cell lines

Authors: Nenad Filipovic, Tijana Djukic, Milos Radovic, Danijela Cvetkovic, Milena Curcic, Snezana Markovic, Aleksandar Peulic, Branislav Jeremic

Published in: Cancer Cell International | Issue 1/2014

Login to get access

Abstract

Background

There is a strong interest in the investigation of extremely low frequency Electromagnetic Fields (EMF) in the clinic. While evidence about anticancer effects exists, the mechanism explaining this effect is still unknown.

Methods

We investigated in vitro, and with computer simulation, the influence of a 50 Hz EMF on three cancer cell lines: breast cancer MDA-MB-231, and colon cancer SW-480 and HCT-116. After 24 h preincubation, cells were exposed to 50 Hz extremely low frequency (ELF) radiofrequency EMF using in vitro exposure systems for 24 and 72 h. A computer reaction-diffusion model with the net rate of cell proliferation and effect of EMF in time was developed. The fitting procedure for estimation of the computer model parameters was implemented.

Results

Experimental results clearly showed disintegration of cells treated with a 50 Hz EMF, compared to untreated control cells. A large percentage of treated cells resulted in increased early apoptosis after 24 h and 72 h, compared to the controls. Computer model have shown good comparison with experimental data.

Conclusion

Using EMF at specific frequencies may represent a new approach in controlling the growth of cancer cells, while computer modelling could be used to predict such effects and make optimisation for complex experimental design. Further studies are required before testing this approach in humans.
Appendix
Available only for authorised users
Literature
1.
go back to reference Polk C: Therapeutic applications of low-frequency sinusoidal and pulsed electric and magnetic fields. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1404-1406. Polk C: Therapeutic applications of low-frequency sinusoidal and pulsed electric and magnetic fields. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1404-1406.
2.
go back to reference Palti Y: Stimulation of internal organs by means of externally applied electrodes. J Appl Physiol. 1966, 21: 1619-1623.PubMed Palti Y: Stimulation of internal organs by means of externally applied electrodes. J Appl Physiol. 1966, 21: 1619-1623.PubMed
3.
go back to reference Besset CA: The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses. Clin Plast Surg. 1985, 12: 259-277. Besset CA: The development and application of pulsed electromagnetic fields (PEMFs) for ununited fractures and arthrodeses. Clin Plast Surg. 1985, 12: 259-277.
4.
go back to reference Chou CK: Radiofrequency hyperthermia in cancer therapy. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1424-1430. Chou CK: Radiofrequency hyperthermia in cancer therapy. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1424-1430.
5.
go back to reference Elson E: Biologic effects of radiofrequency and microwave fields in vivo and in vitro experimental results. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1417-1423. Elson E: Biologic effects of radiofrequency and microwave fields in vivo and in vitro experimental results. The Biomedical Engineering Handbook. Edited by: Bronzino JD. 1995, CRC Press, Boca Raton, FL, 1417-1423.
6.
go back to reference Zimmerman U, Vienken J, Piwat G: Rotation of cells in an alternating electric field: the occurrence of a resonance frequency. Z Naturforsch C. 1981, 36: 173-177. Zimmerman U, Vienken J, Piwat G: Rotation of cells in an alternating electric field: the occurrence of a resonance frequency. Z Naturforsch C. 1981, 36: 173-177.
7.
go back to reference Holzapfel C, Vienken J, Zimmermann U: Rotation of cells in an alternating electric field: theory and experimental proof. J Membr Biol. 1982, 67: 13-26. 10.1007/BF01868644.CrossRefPubMed Holzapfel C, Vienken J, Zimmermann U: Rotation of cells in an alternating electric field: theory and experimental proof. J Membr Biol. 1982, 67: 13-26. 10.1007/BF01868644.CrossRefPubMed
8.
go back to reference Pawlowski P, Szutowicz I, Marszalek P, Fikus M: Bioelectrorheological model of the cell. 5. Electrodestruction of the cellular membrane in alternating electrical field. Biophys J. 1993, 65: 541-549. 10.1016/S0006-3495(93)81056-7.CrossRefPubMedCentralPubMed Pawlowski P, Szutowicz I, Marszalek P, Fikus M: Bioelectrorheological model of the cell. 5. Electrodestruction of the cellular membrane in alternating electrical field. Biophys J. 1993, 65: 541-549. 10.1016/S0006-3495(93)81056-7.CrossRefPubMedCentralPubMed
9.
go back to reference Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzakhi A, Wasserman Y: Disruption of cancer cell replication by alternating electric fields. Cancer Res. 2004, 64: 3288-3295. 10.1158/0008-5472.CAN-04-0083.CrossRefPubMed Kirson ED, Gurvich Z, Schneiderman R, Dekel E, Itzakhi A, Wasserman Y: Disruption of cancer cell replication by alternating electric fields. Cancer Res. 2004, 64: 3288-3295. 10.1158/0008-5472.CAN-04-0083.CrossRefPubMed
10.
go back to reference Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzakhi A: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci. 2007, 104: 10152-10157. 10.1073/pnas.0702916104.CrossRefPubMedCentralPubMed Kirson ED, Dbaly V, Tovarys F, Vymazal J, Soustiel JF, Itzakhi A: Alternating electric fields arrest cell proliferation in animal tumor models and human brain tumors. Proc Natl Acad Sci. 2007, 104: 10152-10157. 10.1073/pnas.0702916104.CrossRefPubMedCentralPubMed
11.
go back to reference Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R: Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer. 2012, 106: 307-313. 10.1038/bjc.2011.523.CrossRefPubMedCentralPubMed Zimmerman JW, Pennison MJ, Brezovich I, Yi N, Yang CT, Ramaker R: Cancer cell proliferation is inhibited by specific modulation frequencies. Br J Cancer. 2012, 106: 307-313. 10.1038/bjc.2011.523.CrossRefPubMedCentralPubMed
12.
go back to reference Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N: Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exper Clin Cancer Res. 2009, 28: 51-10.1186/1756-9966-28-51.CrossRef Barbault A, Costa FP, Bottger B, Munden RF, Bomholt F, Kuster N: Amplitude-modulated electromagnetic fields for the treatment of cancer: discovery of tumor-specific frequencies and assessment of a novel therapeutic approach. J Exper Clin Cancer Res. 2009, 28: 51-10.1186/1756-9966-28-51.CrossRef
13.
go back to reference Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B: Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chin J Cancer. 2013, 32: 573-581. 10.5732/cjc.013.10177.CrossRefPubMedCentralPubMed Zimmerman JW, Jimenez H, Pennison MJ, Brezovich I, Morgan D, Mudry A, Costa FP, Barbault A, Pasche B: Targeted treatment of cancer with radiofrequency electromagnetic fields amplitude-modulated at tumor-specific frequencies. Chin J Cancer. 2013, 32: 573-581. 10.5732/cjc.013.10177.CrossRefPubMedCentralPubMed
14.
go back to reference Fang M, Zhang HQ, Xue SB: Role of Calcium in apoptosis of HL-60 cells induced by harring tonine. Science in China, Ser C. 1998, 41: 600-607. 10.1007/BF02882901.CrossRef Fang M, Zhang HQ, Xue SB: Role of Calcium in apoptosis of HL-60 cells induced by harring tonine. Science in China, Ser C. 1998, 41: 600-607. 10.1007/BF02882901.CrossRef
15.
go back to reference Silva CP, Oliveira CR, Lima MCP: Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem Pharmacol. 1996, 51: 1331-1340. 10.1016/0006-2952(96)00041-X.CrossRefPubMed Silva CP, Oliveira CR, Lima MCP: Apoptosis as a mechanism of cell death induced by different chemotherapeutic drugs in human leukemic T-lymphocytes. Biochem Pharmacol. 1996, 51: 1331-1340. 10.1016/0006-2952(96)00041-X.CrossRefPubMed
16.
go back to reference Zhang X, Zhang H, Zheng C, LI C, Zhang X, Xiong W: Extremely Low Frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels. Cell Biol Int. 2002, 26: 599-603. 10.1006/cbir.2002.0883.CrossRefPubMed Zhang X, Zhang H, Zheng C, LI C, Zhang X, Xiong W: Extremely Low Frequency (ELF) pulsed-gradient magnetic fields inhibit malignant tumour growth at different biological levels. Cell Biol Int. 2002, 26: 599-603. 10.1006/cbir.2002.0883.CrossRefPubMed
17.
go back to reference Harris PA, Lamb J, Heaton B, Wheatley DN: Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields. Cancer Cell Int. 2002, 2: 3-10.1186/1475-2867-2-3.CrossRefPubMedCentralPubMed Harris PA, Lamb J, Heaton B, Wheatley DN: Possible attenuation of the G2 DNA damage cell cycle checkpoint in HeLa cells by extremely low frequency (ELF) electromagnetic fields. Cancer Cell Int. 2002, 2: 3-10.1186/1475-2867-2-3.CrossRefPubMedCentralPubMed
18.
go back to reference Cameron IL, Sun LZ, Short N, Hardman WE, Williams CD: Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int. 2005, 5: 23-10.1186/1475-2867-5-23. doi:10.1186/1475-2867-5-23CrossRefPubMedCentralPubMed Cameron IL, Sun LZ, Short N, Hardman WE, Williams CD: Therapeutic Electromagnetic Field (TEMF) and gamma irradiation on human breast cancer xenograft growth, angiogenesis and metastasis. Cancer Cell Int. 2005, 5: 23-10.1186/1475-2867-5-23. doi:10.1186/1475-2867-5-23CrossRefPubMedCentralPubMed
19.
go back to reference Costa FP, de Oliveira AC, Meirelles R, Machado MCC, Zanesco T, Surjan R, Chammas MC, de Souza RM, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B: Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. Br J Cancer. 2011, 105: 640-648. 10.1038/bjc.2011.292.CrossRefPubMedCentralPubMed Costa FP, de Oliveira AC, Meirelles R, Machado MCC, Zanesco T, Surjan R, Chammas MC, de Souza RM, Morgan D, Cantor A, Zimmerman J, Brezovich I, Kuster N, Barbault A, Pasche B: Treatment of advanced hepatocellular carcinoma with very low levels of amplitude-modulated electromagnetic fields. Br J Cancer. 2011, 105: 640-648. 10.1038/bjc.2011.292.CrossRefPubMedCentralPubMed
20.
go back to reference Gevertz JL, Gillies GT, Torquato S: Simulating tumor growth in confined heterogeneous environments. Phys Biol. 2008, 5: 036010-10.1088/1478-3975/5/3/036010.CrossRefPubMed Gevertz JL, Gillies GT, Torquato S: Simulating tumor growth in confined heterogeneous environments. Phys Biol. 2008, 5: 036010-10.1088/1478-3975/5/3/036010.CrossRefPubMed
21.
go back to reference Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.CrossRef Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth. 1983, 65: 55-63. 10.1016/0022-1759(83)90303-4.CrossRef
22.
go back to reference Baskić D, Popović S, Ristić P, Arsenijević NN: Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int. 2006, 30: 924-932. 10.1016/j.cellbi.2006.06.016.CrossRefPubMed Baskić D, Popović S, Ristić P, Arsenijević NN: Analysis of cycloheximide-induced apoptosis in human leukocytes: fluorescence microscopy using annexin V/propidium iodide versus acridin orange/ethidium bromide. Cell Biol Int. 2006, 30: 924-932. 10.1016/j.cellbi.2006.06.016.CrossRefPubMed
23.
go back to reference Yu Q, Liu Y, Wang C, Sun D, Yang X, Liu Y, Liu J: Chiral Ruthenium(II) polypyridyl complexes: stabilization of g-quadruplex DNA, inhibition of telomerase activity and cellular uptake. PLoS One. 2012, 7 (12): e50902-10.1371/journal.pone.0050902. doi:10.1371/journal.pone.0050902CrossRefPubMedCentralPubMed Yu Q, Liu Y, Wang C, Sun D, Yang X, Liu Y, Liu J: Chiral Ruthenium(II) polypyridyl complexes: stabilization of g-quadruplex DNA, inhibition of telomerase activity and cellular uptake. PLoS One. 2012, 7 (12): e50902-10.1371/journal.pone.0050902. doi:10.1371/journal.pone.0050902CrossRefPubMedCentralPubMed
24.
go back to reference Swanson KR, Brigde C, Murray JD, Ellsworth AC: Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci. 2003, 216: 1-10. 10.1016/j.jns.2003.06.001.CrossRefPubMed Swanson KR, Brigde C, Murray JD, Ellsworth AC: Virtual and real brain tumors: using mathematical modeling to quantify glioma growth and invasion. J Neurol Sci. 2003, 216: 1-10. 10.1016/j.jns.2003.06.001.CrossRefPubMed
25.
go back to reference Rockne R, Alvord EC, Rockhill JK, Swanson KR: A mathematical model for brain tumor response to radiation therapy. J Math Biol. 2009, 58: 561-578. 10.1007/s00285-008-0219-6.CrossRefPubMedCentralPubMed Rockne R, Alvord EC, Rockhill JK, Swanson KR: A mathematical model for brain tumor response to radiation therapy. J Math Biol. 2009, 58: 561-578. 10.1007/s00285-008-0219-6.CrossRefPubMedCentralPubMed
26.
go back to reference Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC: A mathematical model of glioma growth: the effect of extent of surgical resection. Cell Prolif. 1996, 29: 269-288. 10.1111/j.1365-2184.1996.tb01580.x.CrossRefPubMed Woodward DE, Cook J, Tracqui P, Cruywagen GC, Murray JD, Alvord EC: A mathematical model of glioma growth: the effect of extent of surgical resection. Cell Prolif. 1996, 29: 269-288. 10.1111/j.1365-2184.1996.tb01580.x.CrossRefPubMed
27.
go back to reference Tracqui P, Cruywagen GC, Woodward DE, Bartoo GT, Murray JD, Alvord EC: A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth. Cell Prolif. 1995, 28: 17-31. 10.1111/j.1365-2184.1995.tb00036.x.CrossRefPubMed Tracqui P, Cruywagen GC, Woodward DE, Bartoo GT, Murray JD, Alvord EC: A mathematical model of glioma growth: the effect of chemotherapy on spatio-temporal growth. Cell Prolif. 1995, 28: 17-31. 10.1111/j.1365-2184.1995.tb00036.x.CrossRefPubMed
28.
go back to reference Filipovic N, Peulic A, Zdravkovic N, Grbovic-Markovic V, Jurisic-Skevin A: Transient finite element modeling of functional electrical stimulation. Gen Physiol Biophys. 2011, 30: 59-65. 10.4149/gpb_2011_01_59.CrossRefPubMed Filipovic N, Peulic A, Zdravkovic N, Grbovic-Markovic V, Jurisic-Skevin A: Transient finite element modeling of functional electrical stimulation. Gen Physiol Biophys. 2011, 30: 59-65. 10.4149/gpb_2011_01_59.CrossRefPubMed
29.
go back to reference Holland JH: Adaptation in Natural and Artificial Systems. 1975, University of Michigan Press, Ann Arbor Holland JH: Adaptation in Natural and Artificial Systems. 1975, University of Michigan Press, Ann Arbor
30.
go back to reference Nelder J, Mead R: A simplex method for function minimization. Comput J. 1965, 7: 308-313. 10.1093/comjnl/7.4.308.CrossRef Nelder J, Mead R: A simplex method for function minimization. Comput J. 1965, 7: 308-313. 10.1093/comjnl/7.4.308.CrossRef
31.
go back to reference Kirson ED, Schneiderman RS, Dbaly V, Tovarys F, Vymazal J, Itzhaki A: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys. 2009, 9: 1-13. 10.1186/1756-6649-9-1.CrossRefPubMedCentralPubMed Kirson ED, Schneiderman RS, Dbaly V, Tovarys F, Vymazal J, Itzhaki A: Chemotherapeutic treatment efficacy and sensitivity are increased by adjuvant alternating electric fields (TTFields). BMC Med Phys. 2009, 9: 1-13. 10.1186/1756-6649-9-1.CrossRefPubMedCentralPubMed
32.
go back to reference Salzberg M, Kirson E, Palti Y, Rochlitz C: A pilot study with very low intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie. 2008, 31: 362-365. 10.1159/000137713.CrossRefPubMed Salzberg M, Kirson E, Palti Y, Rochlitz C: A pilot study with very low intensity, intermediate-frequency electric fields in patients with locally advanced and/or metastatic solid tumors. Onkologie. 2008, 31: 362-365. 10.1159/000137713.CrossRefPubMed
33.
go back to reference Kirson ED, Giladi M, Gurvich Z, Itzhaki A, Mordechovich D, Schneiderman RS: Alternating electric fields (TTFields) inhibitmetastatic spread of solid tumors to the lungs. Clin Exp Metastasis. 2009, 26: 633-640. 10.1007/s10585-009-9262-y.CrossRefPubMedCentralPubMed Kirson ED, Giladi M, Gurvich Z, Itzhaki A, Mordechovich D, Schneiderman RS: Alternating electric fields (TTFields) inhibitmetastatic spread of solid tumors to the lungs. Clin Exp Metastasis. 2009, 26: 633-640. 10.1007/s10585-009-9262-y.CrossRefPubMedCentralPubMed
34.
go back to reference Schneiderman RS, Shmueli E, Kirson ED, Palti Y: TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that overexpress ABC transporters. BMC Cancer. 2010, 10: 229-10.1186/1471-2407-10-229.CrossRefPubMedCentralPubMed Schneiderman RS, Shmueli E, Kirson ED, Palti Y: TTFields alone and in combination with chemotherapeutic agents effectively reduce the viability of MDR cell sub-lines that overexpress ABC transporters. BMC Cancer. 2010, 10: 229-10.1186/1471-2407-10-229.CrossRefPubMedCentralPubMed
35.
go back to reference Kaszuba-Zwoinska J, Wojcik K, Bereta M, Ziomber A, Pierzchalski P, Rokita E, Marcinkiewicz J, Zaraska W, Thor P: Pulsating electromagnetic field stimulation prevents cell death of puromycin treated u937 cell line. J Physiol Pharmacol. 2010, 61 (2): 201-205.PubMed Kaszuba-Zwoinska J, Wojcik K, Bereta M, Ziomber A, Pierzchalski P, Rokita E, Marcinkiewicz J, Zaraska W, Thor P: Pulsating electromagnetic field stimulation prevents cell death of puromycin treated u937 cell line. J Physiol Pharmacol. 2010, 61 (2): 201-205.PubMed
36.
go back to reference Watson JM, Parrish EA, Rinehart CA: Selective potentiation of gynecologic cancer cell growth in vitro by electromagnetic fields. Gynecol Oncol. 1998, 71: 64-71. 10.1006/gyno.1998.5114.CrossRefPubMed Watson JM, Parrish EA, Rinehart CA: Selective potentiation of gynecologic cancer cell growth in vitro by electromagnetic fields. Gynecol Oncol. 1998, 71: 64-71. 10.1006/gyno.1998.5114.CrossRefPubMed
37.
go back to reference Saliev T, Tachibana K, Bulanin D, Mikhalovsky S, Whitby RD: Bio-effects of non-ionizing electromagnetic fields in context of cancer therapy. Front Biosci (Elite Ed). 2014, 6: 175-184. 10.2741/E700.CrossRef Saliev T, Tachibana K, Bulanin D, Mikhalovsky S, Whitby RD: Bio-effects of non-ionizing electromagnetic fields in context of cancer therapy. Front Biosci (Elite Ed). 2014, 6: 175-184. 10.2741/E700.CrossRef
38.
go back to reference Artacho-Cordón F, Salinas-Asensio Mdel M, Calvente I, Ríos-Arrabal S, León J, Román-Marinetto E, Olea N, Núñez MI: Could radiotherapy effectiveness be enhanced by electromagnetic field treatment?. Int J Mol Sci. 2013, 14: 14974-14995. 10.3390/ijms140714974.CrossRefPubMed Artacho-Cordón F, Salinas-Asensio Mdel M, Calvente I, Ríos-Arrabal S, León J, Román-Marinetto E, Olea N, Núñez MI: Could radiotherapy effectiveness be enhanced by electromagnetic field treatment?. Int J Mol Sci. 2013, 14: 14974-14995. 10.3390/ijms140714974.CrossRefPubMed
39.
go back to reference Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S: Novottf-100a versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012, 48: 2192-2202. 10.1016/j.ejca.2012.04.011.CrossRefPubMed Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbalý V, Ram Z, Villano JL, Rainov N, Weinberg U, Schiff D, Kunschner L, Raizer J, Honnorat J, Sloan A, Malkin M, Landolfi JC, Payer F, Mehdorn M, Weil RJ, Pannullo SC, Westphal M, Smrcka M, Chin L, Kostron H, Hofer S: Novottf-100a versus physician’s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer. 2012, 48: 2192-2202. 10.1016/j.ejca.2012.04.011.CrossRefPubMed
Metadata
Title
Electromagnetic field investigation on different cancer cell lines
Authors
Nenad Filipovic
Tijana Djukic
Milos Radovic
Danijela Cvetkovic
Milena Curcic
Snezana Markovic
Aleksandar Peulic
Branislav Jeremic
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2014
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/s12935-014-0084-x

Other articles of this Issue 1/2014

Cancer Cell International 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine